财经
财经
首页DVAI34 • BVMF
德维特
R$766.82
4月23日, GMT-3 11:23:50 · BRL · BVMF · 免责声明
股票在BR上市的证券总部位于美国
昨日收盘价
R$759.00
当日价格范围
R$766.82 - R$766.82
年度波幅
R$546.63 - R$835.50
市值
103.14亿 USD
平均交易量
14.00
市盈率
-
股息率
-
相关资讯
财务信息
损益表
收入
净收入
(USD)2025年12月年同比变化
收入
36.20亿9.87%
经营支出
6.59亿11.97%
净收入
2.34亿-9.68%
净利润率
6.47-17.79%
每股收益
3.4051.79%
息税折旧摊销前利润
7.38亿12.69%
有效税率
20.05%
总资产
负债总额
(USD)2025年12月年同比变化
现金及短期投资
7.01亿-17.17%
总资产
174.80亿1.13%
负债总额
163.22亿7.42%
权益总额
11.58亿
发行在外的股份
6680.00万
市净率
-79.89
资产回报率
7.87%
资本回报率
9.79%
现金净变动
(USD)2025年12月年同比变化
净收入
2.34亿-9.68%
来自运营的现金
5.41亿-1.26%
投资现金
-1.63亿34.22%
融资现金
-4.15亿26.65%
现金净变动
-3766.70万86.49%
自由现金流
3.96亿16.37%
简介
DaVita Inc., incorporated in Delaware and headquartered in Denver, provides kidney dialysis services through a network of 2,657 outpatient centers in the United States, serving 200,500 patients, and 585 outpatient centers in 14 other countries serving 94,500 patients. The company primarily treats end-stage renal disease, which requires patients to undergo kidney dialysis, often 3 times per week for the rest of their lives unless they receive a kidney transplant via organ donation. In 2025, 68% of the company's revenues came from Medicare and other government-based health insurance programs. In 2025, 89% of the company's patients were covered by government-based health insurance programs. Commercial payers, which accounted for 32% of revenues in 2025, generate nearly all of the company's profit as they reimburse at a much higher rate than government-based health insurance programs. The company is ranked 331st on the Fortune 500. Wikipedia
成立时间
1992
员工数量
78,000
一探究竟
您可能感兴趣的股票
此列表是根据近期的搜索内容、关注的证券以及其他活动生成的。了解详情

所有数据和信息均按“原样”提供,仅供个人参考,并非金融建议,不可用于交易目的,亦不可用于提供投资、税务、法律、会计或其他方面的建议。Google 并非投资顾问,也不是金融顾问,并且对此列表中的任何一家公司或该等公司发行的所有证券不发表任何看法、建议或观点。在进行任何交易之前,请先咨询您的经纪人或金融代表,以便核实价格。了解详情
搜索
清除搜索内容
关闭搜索框
Google 应用
主菜单